Predictors of revascularization
| TIMI 2–3 Flow | P | ||
|---|---|---|---|
| No | Yes | ||
| Demographics (patients) | n = 4 | n = 14 | |
| Age, years (mean ± SD) | 67.5 ± 11.6 | 77.2 ± 10.8 | .14 |
| Admission NIHSS (mean ± SD) | 15.8 ± 5.2 | 16.4 ± 6.3 | .86 |
| Time to angiography, minutes (mean ± SD) | 372 ± 72 | 509 ± 894 | .77 |
| Women (men) | 0 (4) | 10 (4) | .02 |
| Comorbidities (patients) | n = 4 | n = 14 | |
| Hypertension | 4 | 13 | .78 |
| Diabetes mellitus | 1 | 2 | .55 |
| Atrial fibrillation | 2 | 5 | .51 |
| Hyperlipidemia | 3 | 5 | .21 |
| Coronary artery disease | 0 | 5 | .23 |
| Location (lesions) | n = 4 | n = 15 | |
| M1 MCA | 0 | 4 | .35 |
| M2 MCA | 0 | 1 | .79 |
| VBS | 0 | 3 | .47 |
| Any solitary lesion | 0 | 8 | .09 |
| M1 MCA + M2 MCA | 0 | 4 | .35 |
| ICA bifurcation + ICA terminus + M1 MCA | 2 | 0 | .04 |
| ICA bifurcation + M1 MCA | 0 | 3 | .47 |
| ICA terminus + M1 MCA | 2 | 0 | .04 |
| Limited to MCA (M1 or M2 MCA or M1+M2) | 0 | 9 | .05 |
| Limited to MCA or VBS | 0 | 12 | .01 |
| Stent used (lesions) | n = 4 | n = 15 | |
| Neuroform | 4 | 12 | .47 |
| Wingspan | 0 | 3 | .47 |
| Adjunctive treatment (lesions) | n = 4 | n = 15 | |
| IIb/IIIa inhibitor | 3 | 7 | .33 |
| IA thrombolysis | 3 | 9 | .53 |
| IV thrombolysis | 2 | 3 | .27 |
| Merci retriever | 1 | 8 | .33 |
| Angioplasty | 1 | 9 | .25 |
| Clinical outcomes (patients) | n = 4 | n = 14 | |
| mRS score ≤ 3 | 0 | 6 | .16 |
| mRS score ≤ 3 at 3 months | 0 | 4 | .42 |
| NIHSS score reduced by ≥ 4 | 0 | 7 | .11 |
Note:—TIMI indicates Thrombolysis in Myocardial Infarction; NIHSS, National Institutes of Health Stroke Scale; MCA, middle cerebral artery; VBS, vertebrobasilar system; ICA, internal carotid artery; IA, intra-arterial; mRS, modified Rankin Scale.